【brining pheasant for smoking】BioNTech founders warn of vaccine supply gaps - Spiegel
* CEO Sahin says can't fully cover lack of other vaccines
* Says testing BioNTech/Pfizer vaccine on UK COVID variant
* Says could tweak vaccine for strong mutations in 6 weeks
* BioNTech may have more easily storable vaccine by summer
By Douglas Busvine
BERLIN,brining pheasant for smoking Jan 1 (Reuters) - BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc's health regulator and the small size of the order placed by Brussels.
The delays have caused consternation in Germany, where some regions had to temporarily close vaccination centres days after the launch of an inoculation drive on Dec. 27.
"At the moment it doesn't look good - a hole is appearing because there's a lack of other approved vaccines and we have to fill the gap with our own vaccine," BioNTech CEO Ugur Sahin told news weekly Spiegel in an interview.
A shot from Moderna is expected to be cleared by the European Medicines Agency (EMA) on Jan. 6.
German Health Minister Jens Spahn has urged the EMA to also quickly approve a vaccine developed by Oxford University and AstraZeneca that Britain cleared this week. The EU timeline for that treatment remains uncertain.
Sahin said the BioNTech/Pfizer vaccine, which uses messenger RNA to instruct the human immune system to fight the coronavirus, should be able to cope with a variant first detected in Britain that appears to be more contagious.
"We are testing whether our vaccine can also neutralise this variant, and will soon know more," he said.
Asked about coping with a strong mutation, he said it would be possible to tweak the vaccine as required within six weeks - though such new treatments might require additional regulatory approvals.
NEW PRODUCTION LINE PLANNED
Sahin founded BioNTech with his wife, Oezlem Tuereci, who is the company's chief medical officer. Both faulted the EU's decision to spread orders in the expectation that more vaccines would be quickly approved.
The United States ordered 600 million doses of the BioNTech/Pfizer vaccine in July, while the EU waited until November to place an order of half that size.
"At some point it became clear that it would not be possible to deliver so quickly," Tuereci told Spiegel. "By then it was already too late to place follow-on orders."
BioNTech hopes to launch a new production line in Marburg, Germany, in February that could produce 250 million doses in the first half of the year, said Sahin.
Story continues
Talks are under way with contract manufacturers on boosting output and there should be greater clarity by the end of January, he added.
Sahin also said BioNTech would make its vaccine, which requires storage at around minus 70 Celsius (minus 94 Fahrenheit), easier to handle. A next-generation vaccine that would keep at higher temperatures could be ready by late summer. (Reporting by Douglas Busvine; editing by John Stonestreet)
View comments
-
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages CKH, PS, WDR, and EIDX Shareholders to Contact the FirmAmericans have a mix of concern and hope about the economyCoronavirus waivers sent to ‘The Bachelor’ live studio audience membersUPLCQ Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ultra Petroleum Corp. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020CaptionCall Supports “Military Makeover with Montel”Intrepid Congratulates East Plant Employees on Record Monthly Domestic Sales Volumes in AprilVaccines Market Worth $62.2 Billion by 2027, Growing at a CAGR of 5.2% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®Monterey Minerals Provides Update on Drill ProgramCan Guess (GES) Keep the Earnings Surprise Streak Alive?This Broker Just Slashed Their Freelance.com SA (EPA:ALFRE) Earnings Forecasts
下一篇:XFC to Live Stream Inaugural Try-Outs in Michigan on Sept 12 Live on Location at Team SFS-Scorpion Fighting System
- ·FITB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 8, 2020 in the Class Action Filed on Behalf of Fifth Third Bancorp Limited Shareholders
- ·SEC delays decision on tZERO’s proposed security token exchange
- ·Post-Pandemic Retirement Planning Strategy Book Launches on June 1, 2020
- ·Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
- ·Genesco (GCO) Gains But Lags Market: What You Should Know
- ·Taylor Monahan on Crypto’s Divergent Possibilities in 2020
- ·Can Ero Copper Corp. (TSE:ERO) Maintain Its Strong Returns?
- ·LOPE SHAREHOLDER ALERT: Lawsuit Filed For Grand Canyon Investors
- ·Imagine Owning ImmunoPrecise Antibodies (CVE:IPA) And Wondering If The 44% Share Price Slide Is Justified
- ·Argentina teeters on the brink of ninth default
- ·One Metric To Rule Them All: Ground Rents Income Fund PLC (LON:GRIO)
- ·Americans See Record Fall in Consumer Spending, Savings Soar
- ·What Is Parker-Hannifin's (NYSE:PH) P/E Ratio After Its Share Price Tanked?
- ·Is The Goldman Sachs Group (GS) Stock Outpacing Its Finance Peers This Year?
- ·LOPE SHAREHOLDER ALERT: Lawsuit Filed For Grand Canyon Investors
- ·Top Analyst Reports for Apple, Verizon & PayPal
- ·Customer Data Reveals Shift in Peak Online Shopping Hours
- ·Russia's ruling party backs idea to allow Putin to run again for president - RIA
- ·A design trends forecaster calls the coronavirus “an amazing grace for the planet”
- ·Global Care Capital Portfolio Company ViraxClear Secures Supply Contracts to Meet Demand for COVID-19 Antibody Test Kits in Europe and Singapore
- ·Genesco (GCO) Gains But Lags Market: What You Should Know
- ·Broadcom Inc. (AVGO) Stock Moves -1.58%: What You Should Know
- ·GLOBAL MARKETS-Asian shares go flat as China data disappoints
- ·XFC to Live Stream Inaugural Try-Outs in Michigan on Sept 12 Live on Location at Team SFS-Scorpion Fighting System
- ·5 Stocks With Decent Growth Potential to Watch Ahead
- ·Clarivate Analytics Plc (CCC) Q1 Earnings and Revenues Miss Estimates
- ·Livestock Diagnostics Market Worth $1.85 billion by 2027, Growing at a CAGR of 7.8% from 2019- Exclusive Report by Meticulous Research®
- ·Chromadex Corp. to Host Earnings Call
- ·Americans have a mix of concern and hope about the economy
- ·Culp: Q2 Earnings Insights
- ·If You Had Bought NWF Group (LON:NWF) Shares Three Years Ago You'd Have Earned 30% Returns
- ·Brazil manufacturing PMI rises to 38.3 in May from record low 36.0 in April - IHS Markit
- ·Which Consumer Staples Stock Will Grow The Most By 2025?
- ·Toy CEO says it 'sickens' him that people profit from a shortage of supplies to fight coronavirus
- ·IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PaySign, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- ·Green Dot: 3Q Earnings Snapshot